Arcinova: Your Flexible, Fully Integrated R&D Engine—from Discovery to GMP
Deep, integrated Drug Substance expertise across chemistry, solid-state, and analytical disciplines
A flexible model focused on scientific progress, not rigid deliverables
Seamless path from development to GMP manufacture for early clinical supply
A true extension of your team, working at your pace and aligned to your strategy
De-Risk Your Programme
Advance critical development activities: route selection, impurity understanding and solid form before committing to costly GMP manufacture. Generate the right data early to make informed decisions and avoid expensive rework later.
Accelerated Progress Through Integrated Expertise
Reduce delays between activities with chemistry, solid-state, analytical and regulatory capabilities aligned in one dedicated team. Fewer handovers mean faster data, quicker decisions, and uninterrupted progress toward IND.
Cost-Effective & Capital-Efficient
Avoid large upfront API manufacturing costs by scaling investment alongside your programme's progress. With our Early Phase Workbench model, you pay for combined expertise and advancement rather than fixed deliverables, preserving capital while still achieving key milestones toward IND readiness.
Flexibility to Adapt as You Go
Programmes evolve so your resourcing should too. Scale effort up or down and pivot direction as new data emerges. You remain in control of priorities, ensuring your development strategy stays aligned with both data and funding.
Fast Track to GMP Supply
Arcinova can seamlessly transition your programme to early-phase GMP manufacture (e.g. First-in-Human) when you’re ready, eliminating tech transfer delays. This ensures a faster, lower-risk path from development to clinical material when the time is right.
Where Early Phase Workbench supports you most
Customers preparing for IND submission
Programmes requiring early-stage de-risking
Organisations seeking to extend internal capabilities